Shandong Xinhua Pharmaceutical Company Limited (HKG: 0719)

Shandong Xinhua Pharmaceutical Company Statistics

Total Valuation

Shandong Xinhua Pharmaceutical Company has a market cap or net worth of HKD 8.76 billion. The enterprise value is 9.43 billion.

Market Cap	8.76B
Enterprise Value	9.43B

Important Dates

The next estimated earnings date is Thursday, October 24, 2024.

Earnings Date	Oct 24, 2024
Ex-Dividend Date	Sep 4, 2024

Share Statistics

Shandong Xinhua Pharmaceutical Company has 682.41 million shares outstanding. The number of shares has increased by 0.43% in one year.

Shares Outstanding	682.41M
Shares Change (YoY)	+0.43%
Shares Change (QoQ)	+4.60%
Owned by Insiders (%)	0.62%
Owned by Institutions (%)	5.18%
Float	410.81M

Valuation Ratios

The trailing PE ratio is 6.83.

PE Ratio	6.83
Forward PE	n/a
PS Ratio	0.41
PB Ratio	0.71
P/FCF Ratio	164.99
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.14, with an EV/FCF ratio of 435.04.

EV / Earnings	17.83
EV / Sales	1.08
EV / EBITDA	8.14
EV / EBIT	16.02
EV / FCF	435.04

Financial Position

The company has a current ratio of 1.39, with a Debt / Equity ratio of 28.19.

Current Ratio	1.39
Quick Ratio	0.89
Debt / Equity	28.19
Debt / EBITDA	1.30
Debt / FCF	69.53
Interest Coverage	27.86

Financial Efficiency

Return on equity (ROE) is 10.57% and return on invested capital (ROIC) is 5.58%.

Return on Equity (ROE)	10.57%
Return on Assets (ROA)	4.07%
Return on Capital (ROIC)	5.58%
Revenue Per Employee	1.23M
Profits Per Employee	74,433
Employee Count	7,104
Asset Turnover	0.97
Inventory Turnover	5.45

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -6.51% in the last 52 weeks. The beta is -0.03, so Shandong Xinhua Pharmaceutical Company's price volatility has been lower than the market average.

Beta (5Y)	-0.03
52-Week Price Change	-6.51%
50-Day Moving Average	5.32
200-Day Moving Average	5.49
Relative Strength Index (RSI)	48.62
Average Volume (20 Days)	2,757,400

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Shandong Xinhua Pharmaceutical Company had revenue of HKD 8.77 billion and earned 528.77 million in profits. Earnings per share was 0.77.

Revenue	8.77B
Gross Profit	2.32B
Operating Income	588.56M
Pretax Income	541.66M
Net Income	528.77M
EBITDA	1.15B
EBIT	588.56M
Earnings Per Share (EPS)	0.77

Balance Sheet

The company has 1.07 billion in cash and 1.51 billion in debt, giving a net cash position of -436.24 million or -0.64 per share.

Cash & Cash Equivalents	1.07B
Total Debt	1.51B
Net Cash	-436.24M
Net Cash Per Share	-0.64
Equity (Book Value)	5.35B
Book Value Per Share	7.43
Working Capital	1.10B

Cash Flow

In the last 12 months, operating cash flow was 346.58 million and capital expenditures -324.91 million, giving a free cash flow of 21.67 million.

Operating Cash Flow	346.58M
Capital Expenditures	-324.91M
Free Cash Flow	21.67M
FCF Per Share	0.03

Margins

Gross margin is 26.51%, with operating and profit margins of 6.71% and 6.03%.

Gross Margin	26.51%
Operating Margin	6.71%
Pretax Margin	6.18%
Profit Margin	6.03%
EBITDA Margin	13.11%
EBIT Margin	6.71%
FCF Margin	0.25%

Dividends & Yields

This stock pays an annual dividend of 0.27, which amounts to a dividend yield of 5.18%.

Dividend Per Share	0.27
Dividend Yield	5.18%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	34.81%
Buyback Yield	-0.43%
Shareholder Yield	4.75%
Earnings Yield	14.64%
FCF Yield	0.61%

Stock Splits

The last stock split was on July 6, 2018. It was a forward split with a ratio of 1.3.

Last Split Date	Jul 6, 2018
Split Type	Forward
Split Ratio	1.3